Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Identification of commonly dysregulated genes in colorectal cancer by integrating analysis of RNA-Seq data and qRT-PCR validation

Cancer Gene Therapy volume 22, pages 278–284 (2015)Cite this article

Subjects

Abstract

The progression of colorectal cancer (CRC) is a multistep process and metastatic CRC is always incurable; consequently, CRC is the leading cause of cancer-related deaths. There is therefore an urgent need for identifying useful biomarkers with enough sensitivity and specificity to detect this disease at early stages, which will significantly reduce the mortality for this malignancy. In this study, we performed an integrating analysis of different RNA-Seq data sets to find new candidate biomarkers for diagnosis, prognosis and as therapeutic targets for this malignancy, as well as to elucidate the molecular mechanisms of CRC carcinogenesis. We identified 883 differentially expressed genes (DEGs) across the studies between CRC and normal control (NC) tissues by combining five RNA-Seq data sets. Gene function analysis revealed high correlation with carcinogenesis. The top 10 most significantly DEGs were further evaluated by quantitative real-time polymerase chain reaction (qRT-PCR) in both rectal cancer (RC) and colon cancer (CC), and the results matched well with integrating data, suggesting that the method of integrating analysis of different RNA-seq data sets is acceptable. Therefore, integrating analysis of different RNA-seq data sets may be a useful way to overcome the limitation of small sample size in a single RNA-seq study. In addition, our study showed that some genes, such as SIM2, ADAMTS6, FOXD4L4 and DNAH5, may have an important role in the development of CRC, which could be applied for diagnosis, prognosis and as therapy for this malignancy. Our findings would also help to understand the pathology of CRC.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

References

  1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM . Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010; 127: 2893–2917.

    Article  CAS  Google Scholar 

  2. Siegel R, Naishadham D, Jemal A . Cancer statistics, 2013. CA 2013; 63: 11–30.

    PubMed  Google Scholar 

  3. Bass AJ, Lawrence MS, Brace LE, Ramos AH, Drier Y, Cibulskis K et al. Genomic sequencing of colorectal adenocarcinomas identifies a recurrent VTI1A-TCF7L2 fusion. Nat Genet 2011; 43: 964–968.

    Article  CAS  Google Scholar 

  4. Issa JP . CpG island methylator phenotype in cancer. Nat Rev Cancer 2004; 4: 988–993.

    Article  CAS  Google Scholar 

  5. Markowitz SD, Bertagnolli MM . Molecular origins of cancer: Molecular basis of colorectal cancer. N Engl J Med 2009; 361: 2449–2460.

    Article  CAS  Google Scholar 

  6. Zoratto F, Rossi L, Verrico M, Papa A, Basso E, Zullo A et al. Focus on genetic and epigenetic events of colorectal cancer pathogenesis: implications for molecular diagnosis. Tumour Biol 2014; 35: 6195–6206.

    Article  CAS  Google Scholar 

  7. Letellier E, Schmitz M, Baig K, Beaume N, Schwartz C, Frasquilho S et al. Identification of SOCS2 and SOCS6 as biomarkers in human colorectal cancer. Br J Cancer 2014; 111: 726–735.

    Article  CAS  Google Scholar 

  8. Marioni JC, Mason CE, Mane SM, Stephens M, Gilad Y . RNA-seq: an assessment of technical reproducibility and comparison with gene expression arrays. Genome Res 2008; 18: 1509–1517.

    Article  CAS  Google Scholar 

  9. Oshlack A, Robinson MD, Young MD . From RNA-seq reads to differential expression results. Genome Biol 2010; 11: 220.

    Article  CAS  Google Scholar 

  10. Xu X, Zhang Y, Williams J, Antoniou E, McCombie WR, Wu S et al. Parallel comparison of Illumina RNA-Seq and Affymetrix microarray platforms on transcriptomic profiles generated from 5-aza-deoxy-cytidine treated HT-29 colon cancer cells and simulated datasets. BMC Bioinformatics 2013; 14 (Suppl 9): S1.

    Article  Google Scholar 

  11. Siddiqui AS, Delaney AD, Schnerch A, Griffith OL, Jones SJ, Marra MA . Sequence biases in large scale gene expression profiling data. Nucleic Acid Res 2006; 34: e83–e83.

    Article  Google Scholar 

  12. Feichtinger J, Thallinger GG, McFarlane RJ, Larcombe LD . Microarray meta-analysis: From data to expression to biological relationships. In: Computational Medicine. Springer, Vienna, Austria, 2012, pp 59–77.

    Chapter  Google Scholar 

  13. Ramasamy A, Mondry A, Holmes CC, Altman DG . Key issues in conducting a meta-analysis of gene expression microarray datasets. PLoS Med 2008; 5: e184.

    Article  Google Scholar 

  14. Rau A, Marot G, Jaffrezic F . Differential meta-analysis of RNA-seq data from multiple studies. BMC Bioinformatics 2014; 15: 91.

    Article  Google Scholar 

  15. Sonachalam M, Shen J, Huang H, Wu X . Systems biology approach to identify gene network signatures for colorectal cancer. Front Genet 2012; 3: 80.

    Article  CAS  Google Scholar 

  16. Shi M, Beauchamp RD, Zhang B . A network-based gene expression signature informs prognosis and treatment for colorectal cancer patients. PloS One 2012; 7: e41292.

    Article  CAS  Google Scholar 

  17. Barrett T, Wilhite SE, Ledoux P, Evangelista C, Kim IF, Tomashevsky M et al. NCBI GEO: archive for functional genomics data sets—update. Nucleic Acid Res 2013; 41: D991–D995.

    Article  CAS  Google Scholar 

  18. Trapnell C, Williams BA, Pertea G, Mortazavi A, Kwan G, van Baren MJ et al. Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. Nat Biotechnol 2010; 28: 511–515.

    Article  CAS  Google Scholar 

  19. Trapnell C, Pachter L, Salzberg SL . TopHat: discovering splice junctions with RNA-Seq. Bioinformatics 2009; 25: 1105–1111.

    Article  CAS  Google Scholar 

  20. Reimers M, Carey VJ . Bioconductor: an open source framework for bioinformatics and computational biology. Method Enzymol 2006; 411: 119–134.

    Article  CAS  Google Scholar 

  21. Tabas-Madrid D, Nogales-Cadenas R, Pascual-Montano A . GeneCodis3: a non-redundant and modular enrichment analysis tool for functional genomics. Nucleic Acid Res 2012; 40: W478–W483.

    Article  CAS  Google Scholar 

  22. Giot L, Bader JS, Brouwer C, Chaudhuri A, Kuang B, Li Y et al. A protein interaction map of Drosophila melanogaster. science 2003; 302: 1727–1736.

    Article  CAS  Google Scholar 

  23. Li S, Armstrong CM, Bertin N, Ge H, Milstein S, Boxem M et al. A map of the interactome network of the metazoan C. elegans. Science 2004; 303: 540–543.

    Article  CAS  Google Scholar 

  24. Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res 2003; 13: 2498–2504.

    Article  CAS  Google Scholar 

  25. Fleming NI, Jorissen RN, Mouradov D, Christie M, Sakthianandeswaren A, Palmieri M et al. SMAD2, SMAD3 and SMAD4 mutations in colorectal cancer. Cancer Res 2013; 73: 725–735.

    Article  CAS  Google Scholar 

  26. Shin YJ, Kim MS, Kim MS, Lee J, Kang M, Jeong JH . High-mobility group box 2 (HMGB2) modulates radioresponse and is downregulated by p53 in colorectal cancer cell. Cancer Biol Ther 2013; 14: 213–221.

    Article  CAS  Google Scholar 

  27. Xie T, D’Ario G, Lamb JR, Martin E, Wang K, Tejpar S et al. A comprehensive characterization of genome-wide copy number aberrations in colorectal cancer reveals novel oncogenes and patterns of alterations. PloS One 2012; 7: e42001.

    Article  CAS  Google Scholar 

  28. Joyce T, Oikonomou E, Kosmidou V, Makrodouli E, Bantounas I, Avlonitis S et al. A molecular signature for oncogenic BRAF in human colon cancer cells is revealed by microarray analysis. Curr Cancer Drug Target 2012; 12: 873–898.

    Article  CAS  Google Scholar 

  29. Lee S, Bang S, Song K, Lee I . Differential expression in normal-adenoma-carcinoma sequence suggests complex molecular carcinogenesis in colon. Oncol Rep 2006; 16: 747–754.

    PubMed  Google Scholar 

  30. Gutschner T, Hammerle M, Pazaitis N, Bley N, Fiskin E, Uckelmann H et al. Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2BP1) is an important protumorigenic factor in hepatocellular carcinoma. Hepatology 2014; 59: 1900–1911.

    Article  CAS  Google Scholar 

  31. DeYoung MP, Tress M, Narayanan R . Identification of Down’s syndrome critical locus gene SIM2-s as a drug therapy target for solid tumors. Proc Natl Acad Sci USA 2003; 100: 4760–4765.

    Article  CAS  Google Scholar 

  32. Lee KF, Tam YT, Zuo Y, Cheong AW, Pang RT, Lee NP et al. Characterization of an acrosome protein VAD1.2/AEP2 which is differentially expressed in spermatogenesis. Mol Hum Reprod 2008; 14: 465–474.

    Article  CAS  Google Scholar 

  33. Bret C, Hose D, Reme T, Kassambara A, Seckinger A, Meissner T et al. Gene expression profile of ADAMs and ADAMTSs metalloproteinases in normal and malignant plasma cells and in the bone marrow environment. Exp Hematol 2011; 39: 546–557 e8.

    Article  CAS  Google Scholar 

  34. Wierinckx A, Auger C, Devauchelle P, Reynaud A, Chevallier P, Jan M et al. A diagnostic marker set for invasion, proliferation, and aggressiveness of prolactin pituitary tumors. Endocrine-related Cancer 2007; 14: 887–900.

    Article  CAS  Google Scholar 

  35. Li JN, Zhao L, Wu J, Wu B, Yang H, Zhang HH et al. Differences in gene expression profiles and carcinogenesis pathways between colon and rectal cancer. J Digestive Dis 2012; 13: 24–32.

    Article  Google Scholar 

  36. Huang YW, Jansen RA, Fabbri E, Potter D, Liyanarachchi S, Chan MW et al. Identification of candidate epigenetic biomarkers for ovarian cancer detection. Oncol Rep 2009; 22: 853–861.

    Article  CAS  Google Scholar 

  37. Hornef N, Olbrich H, Horvath J, Zariwala MA, Fliegauf M, Loges NT et al. DNAH5 mutations are a common cause of primary ciliary dyskinesia with outer dynein arm defects. Am J Respir Crit Care Med 2006; 174: 120–126.

    Article  CAS  Google Scholar 

  38. Walker BA, Wardell CP, Melchor L, Hulkki S, Potter NE, Johnson DC et al. Intraclonal heterogeneity and distinct molecular mechanisms characterize the development of t(4;14) and t(11;14) myeloma. Blood 2012; 120: 1077–1086.

    Article  CAS  Google Scholar 

  39. Lin C, Smith ER, Takahashi H, Lai KC, Martin-Brown S, Florens L et al. AFF4, a component of the ELL/P-TEFb elongation complex and a shared subunit of MLL chimeras, can link transcription elongation to leukemia. Mol Cell 2010; 37: 429–437.

    Article  CAS  Google Scholar 

  40. Wu J, Lin Y, Xu W, Li Z, Fan W . A mutation in the type II hair keratin KRT86 gene in a Han family with monilethrix. J Biomed Res 2011; 25: 49–55.

    Article  Google Scholar 

  41. Golanska E, Sieruta M, Gresner SM, Hulas-Bigoszewska K, Corder EH, Styczynska M et al. Analysis of APBB2 gene polymorphisms in sporadic Alzheimer’s disease. Neurosci Lett 2008; 447: 164–166.

    Article  CAS  Google Scholar 

Download references

Author information

Author notes

  1. W H Xiao and X L Qu: These authors contributed equally to this work.

Authors and Affiliations

  1. Department of Oncology, The First affiliated Hospital of PLA General Hospital, Beijing, China

    W H Xiao, X L Qu, X M Li, H X Zhao, S Wang & X Zhou

  2. Beijing Yangshen Bioinformatic Technology, Beijing, China

    Y L Sun

Authors
  1. W H Xiao
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. X L Qu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. X M Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Y L Sun
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. H X Zhao
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. S Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. X Zhou
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to W H Xiao.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Additional information

Supplementary Information accompanies the paper on Cancer Gene Therapy website

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Xiao, W., Qu, X., Li, X. et al. Identification of commonly dysregulated genes in colorectal cancer by integrating analysis of RNA-Seq data and qRT-PCR validation. Cancer Gene Ther 22, 278–284 (2015). https://doi.org/10.1038/cgt.2015.20

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/cgt.2015.20

This article is cited by

Search

Advanced search

Quick links